This inventor holds 1 USPTO granted patent. Top assignee: Eikonizo Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dean Hickman and HDAC6 Inhibitor Innovation.
Introduction
Dean Hickman is an inventor associated with Belmont, Massachusetts, and Eikonizo Therapeutics, Inc. His patent work concerns compounds designed to selectively inhibit HDAC6, a protein linked to several diseases.
Latest Patents
Hickman is named on 1 patent: “HDAC6 Inhibitors and Uses Thereof.” The patent describes compounds that selectively inhibit HDAC6, along with pharmaceutical compositions and kits containing those compounds. It also covers methods of treating HDAC6-related diseases and disorders, including cancer and Alzheimer’s disease, by administering the compounds or compositions.
Career Highlights
Hickman’s listed patent reflects research into potential therapeutic applications of selective HDAC6 inhibition. The disclosed approaches address diseases associated with HDAC6 activity and include both candidate compounds and methods for their use.
Collaborations
Hickman’s listed coworker is Florence Fevrier Wagner. His patent work is associated with Eikonizo Therapeutics, Inc.
Conclusion
Dean Hickman’s patent contribution focuses on selective HDAC6 inhibitors and their potential use in treating diseases such as cancer and Alzheimer’s disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile